首页 正文

An updated patent review of small-molecule c-Met kinase inhibitors (2018-present)

{{output}}
Introduction: c-Met tyrosine kinase receptor is a high-affinity ligand of hepatocyte growth factor (HGF). c-Met is widely expressed in a variety of normal human tissues, but shows abnormally high expression, amplification or muta... ...